Track topics on Twitter Track topics that are important to you
Egalet a/s is focused on the development of innovative pharmaceutical products utilizing the Company’s proprietary, erosion-based, controlled-release technology, Egalet®, and a novel formulation system, Parvulet®, aimed at the pediatric market. Egalet’s product pipeline currently has four products in clinical development, two of which are entering late-stage pivotal studies in the cardiovascular and pain markets.
Phone: 45 44 47 80 80
Fax: 45 44 47 24 25
Egalet says its share move up a hefty 38.55% after announcing positive top-line trial results from a…
"The health and safety of our players is paramount and we're proud to partner with Egalet, a company committed to providing innovative pain medications," said Read more...
NEW YORK, NY / ACCESSWIRE / August 9, 2017 / Egalet Corporation (NASDAQ: EGLT) will be discussing their earnings results in their Q2 Earnings Call to be held on Wednesday, August 9, 2017 at 4:30 PM...
Today's Daily Dose brings you news about Aerie's progress in phase II trial of glaucoma drug in Japan; phase III results of Egalet's pain pill; FDA approval of GlaxoSmithKline's COPD drug; expanded la...
WAYNE, Pa., Sept. 6, 2017 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercia...
The purpose of the study is to evaluate the pharmacokinetics of Egalet® morphine when administered with alcohol and compare to administration with water.
The purpose of this study is to evaluate the safety and tolerability of Egalet-002 in opioid-experienced patients with moderate-to-severe chronic noncancer pain.
The purpose of this study is to determine the analgesic efficacy of Egalet-002 twice daily (BID) in patients with moderate-to-severe chronic low back pain
The purpose of the study is to determine the effect of Egalet® Morphine once daily compared to MST Continus twice daily on pain intensity and use of rescue medication for break through p...
The purpose of this study is to compare the efficacy of the Egalet® controlled release formulation to an immediate release Carvedilol tablet.
Egalet a/s is focused on the development of innovative pharmaceutical products utilizing the Company’s proprietary, erosion-based, controlled-release technology, Egalet®, and a novel formulation sy...
We have published hundreds of Egalet a/s news stories on BioPortfolio along with dozens of Egalet a/s Clinical Trials and PubMed Articles about Egalet a/s for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Egalet a/s Companies in our database. You can also find out about relevant Egalet a/s Drugs and Medications on this site too.
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...
Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...